Treatment of Hepatitis C Infection in Renal Transplant Recipients: The Long Wait Is Over

被引：17
|
作者：
Saxena, V. [1 ]
Terrault, N. A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷 / 05期
关键词：
VIRUS;
D O I：
10.1111/ajt.13697
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1345 / 1347
页数：3
相关论文
共 50 条
  • [21] Long-term investigation of hepatitis G virus infection in renal transplant recipients with and without hepatitis B and C co-infection
    Meisel, H
    Reip, A
    Krüger, DH
    Budde, K
    Fritsche, L
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1382 - 1383
  • [22] LONG-TERM OUTCOMES OF HEART TRANSPLANT RECIPIENTS WITH HEPATITIS C INFECTION
    Stepanova, M.
    De Avila, L.
    Jeffers, T.
    Wong, R.
    Ahmed, A.
    Younossi, Z. M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S554 - S554
  • [23] Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
    Eisenberger, Ute
    Friebus-Kardash, Justa
    Guberina, Hana
    Kribben, Andreas
    Witzke, Oliver
    Willuweit, Katharina
    Gerken, Guido
    Herzer, Kerstin
    TRANSPLANTATION DIRECT, 2019, 5 (01):
  • [24] Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients
    Hanzada Mohamed El Maghrabi
    Ahmed Yahia Elmowafy
    Ayman Fathi Refaie
    Mohammed Adel Elbasiony
    Gamal Elsayed Shiha
    Lionel Rostaing
    Mohamed Adel Bakr
    International Urology and Nephrology, 2019, 51 : 2295 - 2304
  • [25] Combination treatment with pegylated interferon A and ribavirin in potential renal transplant recipients with chronic hepatitis C infection.
    Donaldson, K
    Pall, A
    Dillon, J
    Henderson, I
    Walsh, S
    SCOTTISH MEDICAL JOURNAL, 2006, 51 (01) : 55 - 55
  • [26] The Effect of Pretransplant Chronic Hepatitis C Virus Infection Treatment on Graft and Patient Survival in Renal Transplant Recipients
    Korkmaz, Murat
    Faki, Sevgul
    Ocal, Serkan
    Harmanci, Ozgur
    Ensaroglu, Fatih
    Selcuk, Haldun
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 188 - 192
  • [27] Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients
    El Maghrabi, Hanzada Mohamed
    Elmowafy, Ahmed Yahia
    Refaie, Ayman Fathi
    Elbasiony, Mohammed Adel
    Shiha, Gamal Elsayed
    Rostaing, Lionel
    Bakr, Mohamed Adel
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (12) : 2295 - 2304
  • [28] Influence of chronic hepatitis C virus infection on lymphocyte phenotype in renal transplant recipients
    Sens, YAD
    Forte, WCN
    Malafronte, P
    Ferro, A
    Magalhaes, AO
    Silva, HGC
    Souza, JF
    Miorin, LA
    Jabur, P
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) : 466 - 468
  • [29] Impact of Hepatitis C Virus Infection on Bone Mineral Density in Renal Transplant Recipients
    Huang, Wen-Hung
    Yu, Mei-Ching
    Huang, Jeng-Yi
    Lai, Ping-Chin
    PLOS ONE, 2013, 8 (05):
  • [30] Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients
    Gutierrez, Julio A.
    Carrion, Andres F.
    Avalos, Danny
    O'Brien, Christopher
    Martin, Paul
    Bhamidimarri, Kalyan Ram
    Peyton, Adam
    LIVER TRANSPLANTATION, 2015, 21 (06) : 823 - 830
12345